Core Technology
1. Technology Leader
BIOQINGLAM is the technology leader in painless transdermal delivery of dissolving microneedles, with mature high-precision microneedle mold preparation technology, stable microneedle automation, and modular production processes. We have independently applied for eighteen patents, including twelve invention patents, one authorized patent, two PCT applications, three utility model patents, and three exterior design patents.
2. One-Stop Service for Preparation Development
BIOQINGLAM has a microneedle drug delivery R&D center of nearly 5,000 square meters, fully equipped with animal experiments, preparation development, process research, quality research, equipment development, quality system assurance, regulations, IT personnel; equipped with LC-MS, UPLC, HPLC, ELISA, CE, qPCR, SDS-PAGE, and other instruments; provide one-stop service for IND declaration including the conceptual study of pharmacodynamic pharmacokinetics, formulation development, production process development, quality research, and stability research.
3. cGMP Production Workshop and Automatic Mass Production
The cGMP workshop area for various types of drug-loaded microneedle patches that can meet sterility requirements is nearly 3,000 square meters. Microneedle patch preparation batches can be flexibly formulated and implemented in fully automated production, and the output reaches 4200 pieces per batch.
4. Diversity and Safety of Drug Delivery Routes
BIOQINGLAM already has an R&D pipeline of nucleic acid drugs, monoclonal antibodies, peptides, and chemical drugs. Moreover, the above pipelines have made breakthroughs to meet the research and development of various types of drugs. Customizable needle parameters enable painless drug delivery, and unique drug delivery routes push through dose limits for better safety.